It would make a lot of sense now that IMU is having CAR-T as one of its pipelines. CHM's Brain Cancer and NK-cell technologies are both close to start their registrational trials, that would mean in 2025 IMU could have 4 Rego trials. Imagine, if all 4 would be approved in 2026 / 2027.
CHM is atm valued worthless, but the GBM CAR-T is atm the most advanced GBM treatment - Imagine that! Then they are doing an NK-Cell AML trial in the US, approached by MD Anderson Texas due to fantastic ph 1 / 2 results. Again, CHM valued worthless.
Plus they got the green light to start the first ever direct attacking solid cancer CAR-T based on CD 17. That alone is more worth than $ ZERO.
And Hopper holds 19.99% of CHM. A t/o at 20c, about 200m EV, would make him a bit richer too. And me too, LOL.
GLTA
- Forums
- ASX - By Stock
- IMU
- Media Thread
Media Thread, page-13380
-
- There are more pages in this discussion • 1,625 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $389.5M |
Open | High | Low | Value | Volume |
5.4¢ | 5.5¢ | 5.3¢ | $188.8K | 3.516M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 141231 | 5.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.4¢ | 22869 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 13225 | 0.054 |
8 | 338457 | 0.053 |
12 | 1995459 | 0.052 |
28 | 3480570 | 0.051 |
74 | 6455639 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.053 | 13226 | 2 |
0.054 | 42000 | 2 |
0.055 | 658518 | 6 |
0.056 | 896185 | 10 |
0.057 | 1624353 | 11 |
Last trade - 16.10pm 01/08/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |